Real-world survey of pneumonitis/radiation pneumonitis among patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy after durvalumab approval: A multicenter retrospective cohort study (HOPE-005/CRIMSON).

Go Saito,Yuko Oya,Yoshihiko Taniguchi,Hayato Kawachi,Daichi Fujimoto,Hirotaka Matsumoto,Shunichiro Iwasawa,Hidekazu Suzuki,Takayuki Niitsu,Eisaku Miyauchi,Takashi Yokoi,Miho Mitsui,Takeshi Uenami,Yoshihiko Sakata,Daisuke Arai,Asuka Okada,Satoshi Hara,Shunsuke Teraoka,Masaki Kokubo

Real-world survey of pneumonitis/radiation pneumonitis among patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy after durvalumab approval: A multicenter retrospective cohort study (HOPE-005/CRIMSON).

2020

Go Saito
Yuko Oya
Yoshihiko Taniguchi
Hayato Kawachi
Daichi Fujimoto
Hirotaka Matsumoto
Shunichiro Iwasawa
Hidekazu Suzuki
Takayuki Niitsu
Eisaku Miyauchi
Takashi Yokoi
Miho Mitsui
Takeshi Uenami
Yoshihiko Sakata
Daisuke Arai
Asuka Okada
Satoshi Hara
Shunsuke Teraoka
Masaki Kokubo

9039Background: Durvalumab was approved as a consolidation therapy after chemoradiotherapy (CRT) for locally advanced non-small cell lung cancer (NSCLC) and established as the standard of care. How...

Keywords:

Pneumonitis
Oncology
Lung cancer
Durvalumab
non small cell
Pathology
Radiation Pneumonitis
locally advanced
Internal medicine
Retrospective cohort study
Chemoradiotherapy
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations